11 December 2018 - The Biosafety Advisory Council issues a positive advice (with conditions) for this trial
File:
Trial reference:
Phase III trial investigating a AAV vector containing a variant of human factor IX gene administered to adult subjects with severe or moderately-severe hemophilia B